Vessi Medical
Agent42Agent Readiness: 42/100. Above median. Measured by StartupHub.ai. Median 41.Israeli startup developing surface cryotherapy for non-muscle-invasive bladder cancer.
About
Vessi Medical has developed a new ablative approach for treating non-muscle invasive bladder cancer using surface cryotherapy. Their minimally invasive solution utilizes extreme cold via a disposable catheter inserted into the bladder, offering an office-based alternative to surgery. This technology aims to provide an effective treatment with reduced side effects and lower healthcare costs for patients with this condition.
Key facts
At-a-glance profile data
- Website
- trendlines.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2015
- Employees
- 9
- Total funding
- $18M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 14 Feb 2024 | Series A | $17M | - |
| 1 Sept 2020 | Seed | $2M | The Trendlines Group |
Tech stack
Detected on trendlines.com, last scanned 30 Aug 2026. Run your own scan
- Compliance
- GDPR
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
Frequently asked
How much funding has Vessi Medical raised?
Vessi Medical has raised a total of $18M in funding. The most recent round on record is Series A.
How many employees does Vessi Medical have?
Vessi Medical has approximately 9 people on record.